BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22285021)

  • 1. Single nucleotide polymorphism array-based karyotyping shows sequential genomic changes from monosomy to copy-neutral loss of heterozygosity of chromosome 7 and 20q deletion within a balanced translocation t(14;20) in AML.
    Huh J; Mun YC; Seong CM; Chung WS
    Cancer Genet; 2011 Dec; 204(12):682-6. PubMed ID: 22285021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single nucleotide polymorphism array-based karyotyping in acute myeloid leukemia or myelodysplastic syndrome with trisomy 8 as the sole chromosomal abnormality.
    Hahm C; Mun YC; Seong CM; Han SH; Chung WS; Huh J
    Acta Haematol; 2013; 129(3):154-8. PubMed ID: 23208021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.
    Huh J; Tiu RV; Gondek LP; O'Keefe CL; Jasek M; Makishima H; Jankowska AM; Jiang Y; Verma A; Theil KS; McDevitt MA; Maciejewski JP
    Genes Chromosomes Cancer; 2010 Apr; 49(4):390-9. PubMed ID: 20095039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional genomic aberrations identified by single nucleotide polymorphism array-based karyotyping in an acute myeloid leukemia case with isolated del(20q) abnormality.
    Hahm C; Mun YC; Seong CM; Chung WS; Huh J
    Ann Lab Med; 2012 Nov; 32(6):445-9. PubMed ID: 23130347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad copy neutral-loss of heterozygosity regions and rare recurring copy number abnormalities in normal karyotype-acute myeloid leukemia genomes.
    Barresi V; Romano A; Musso N; Capizzi C; Consoli C; Martelli MP; Palumbo G; Di Raimondo F; Condorelli DF
    Genes Chromosomes Cancer; 2010 Nov; 49(11):1014-23. PubMed ID: 20725993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide high density single-nucleotide polymorphism array-based karyotyping improves detection of clonal aberrations including der(9) deletion, but does not predict treatment outcomes after imatinib therapy in chronic myeloid leukemia.
    Huh J; Jung CW; Kim JW; Kim HJ; Kim SH; Shin MG; Kim YK; Kim HJ; Suh JS; Moon JH; Sohn SK; Nam GH; Lee JE; Kim DH
    Ann Hematol; 2011 Nov; 90(11):1255-64. PubMed ID: 21384125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
    Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
    J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide genetic characterization of an atypical meningioma by single-nucleotide polymorphism array-based mapping and classical cytogenetics.
    Krupp W; Holland H; Koschny R; Bauer M; Schober R; Kirsten H; Livrea M; Meixensberger J; Ahnert P
    Cancer Genet Cytogenet; 2008 Jul; 184(2):87-93. PubMed ID: 18617056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA profiling by arrayCGH in acute myeloid leukemia and myelodysplastic syndromes.
    Suela J; Alvarez S; Cigudosa JC
    Cytogenet Genome Res; 2007; 118(2-4):304-9. PubMed ID: 18000384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse prognostic impact of abnormal lesions detected by genome-wide single nucleotide polymorphism array-based karyotyping analysis in acute myeloid leukemia with normal karyotype.
    Yi JH; Huh J; Kim HJ; Kim SH; Kim HJ; Kim YK; Sohn SK; Moon JH; Kim SH; Kim KH; Won JH; Mun YC; Kim H; Park J; Jung CW; Kim DH
    J Clin Oncol; 2011 Dec; 29(35):4702-8. PubMed ID: 22084373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dicentric chromosomes and 20q11.2 amplification in MDS/AML with apparent monosomy 20.
    Mackinnon RN; Campbell LJ
    Cytogenet Genome Res; 2007; 119(3-4):211-20. PubMed ID: 18253031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic gains and losses influence expression levels of genes located within the affected regions: a study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q.
    Schoch C; Kohlmann A; Dugas M; Kern W; Hiddemann W; Schnittger S; Haferlach T
    Leukemia; 2005 Jul; 19(7):1224-8. PubMed ID: 15902281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
    Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
    Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; De Braekeleer M
    Eur J Haematol; 2007 Jun; 78(6):457-67. PubMed ID: 17391336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different characteristics identified by single nucleotide polymorphism array analysis in leukemia suggest the need for different application strategies depending on disease category.
    Huh J; Jung CW; Kim HJ; Kim YK; Moon JH; Sohn SK; Kim HJ; Min WS; Kim DH
    Genes Chromosomes Cancer; 2013 Jan; 52(1):44-55. PubMed ID: 23023762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of a new human acute myelocytic leukemia cell line SH-2 with a loss of Y chromosome, a derivative chromosome 16 resulting from an unbalanced translocation between chromosomes 16 and 17, monosomy 17, trisomy 19, and p53 alteration.
    Qiu H; Xue Y; Zhang J; Pan J; Dai H; Wu Y; Wang Y; Chen S; Wu D
    Exp Hematol; 2008 Nov; 36(11):1487-95. PubMed ID: 18715689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phenomenon of the evolution of clonal chromosomal abnormalities in childhood acute myeloid leukemia].
    Andreeva SV; Drozdova VD; Kavardakova NV
    Tsitol Genet; 2010; 44(3):41-52. PubMed ID: 20608159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.